EryDel S.p.A. is a Drug Delivery Company specialized in the development of drugs and diagnostics delivered through human red blood cells via a proprietary medical device technology.

Latest news

20-02-2014

 EryDel today announced the publication in Orphanet Journal of Rare Disease (Chessa et al. 2014) of the results of a Phase II six-month study in Ataxia Telangiectasia patients.

» read more

Contact Us go

Urbino (PU) Via Sasso 36, 61029 - IT
Phone +39 0722 378711 - Fax: +39 0722 328166 - info@erydel.com

Bresso (MI)  Via L. Ariosto 23-25, 20091 - IT
Phone +39 02 36504470 - Fax: +39 02 36504474  - info@erydel.com